Under what circumstances would you offer chemotherapy or consider a circulating tumor DNA test to decide upon adjuvant chemotherapy for stage IA grade 2 endometrioid ovarian carcinoma following comprehensive surgical staging?
Are there primary tumor characteristics, such as tumor size, presence of ascites with negative cytology, or tumor grade that affect your decision?